THE WHAT? Henkel has reported a 7.8 percent organic group sales growth for FY2021, to around 20.1 billion euros.
THE DETAILS The company saw a particularly positive effect thanks to the ‘significant recovery’ in demand in industrial and Hair Salon businesses.
Looking at its consumer goods business, demand in many categories returned to more normal patterns compared to the previous year (2020), when demand was particularly strong for hygiene and cleaning products as well as hair colorants and less so for styling products.
Henkel highlighted that the impact of significantly increasing raw material and logistics prices as well as currency effects weighed on profitability in fiscal 2021.
Geographically, the emerging markets achieved double-digit organic sales growth of 15.4 percent, while the businesses in the mature markets recorded a good organic sales performance of 2.5 percent.
The Beauty Care business unit saw a 2 percent sales decline in FY2021, to 3,678 million euros, while organically, sales increased by 1.4 percent.
According to Henkel, “While the significant recovery in the hair salon business had a positive effect, the consumer business was impacted by a normalization of demand in the body care category and recorded a declining development.”
THE WHY? Henkel was able to more than offset the impact on its earnings thanks to higher sales volumes, successful price increases, active cost management and ongoing structural adjustments.
The company drilled down on its Purposeful Growth agenda, which saw it announce plans to merge the units Laundry & Home Care and Beauty Care into one new business unit: Henkel Consumer Brands.
Henkel says, “With the new business unit, Henkel will build one multi-category platform for the complete consumer business under one roof, including many iconic brands such as Persil and Schwarzkopf as well as the Hair Professional business. The new business unit will have around 10 billion euros in sales. The merger is designed to drive growth and profitability for the consumer business and the company.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
